Shinva Medical InstrumentLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Shinva Medical InstrumentLtd heeft een totaal eigen vermogen van CN¥7.9B en een totale schuld van CN¥1.1B, wat de schuld-eigenvermogensverhouding op 13.5% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥15.4B en CN¥7.5B. De EBIT Shinva Medical InstrumentLtd is CN¥712.6M waardoor de rentedekking -10.8 is. Het heeft contanten en kortetermijnbeleggingen van CN¥2.5B.

Belangrijke informatie

13.5%

Verhouding schuld/eigen vermogen

CN¥1.06b

Schuld

Rente dekkingsratio	-10.8x
Contant	CN¥2.52b
Aandelen	CN¥7.90b
Totaal verplichtingen	CN¥7.49b
Totaal activa	CN¥15.39b

Recente financiële gezondheidsupdates

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Aug 08

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Recent updates

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥9.4B ) 600587 } overtreffen de korte termijn passiva ( CN¥7.1B ).

Langlopende schulden: De kortetermijnactiva 600587 ( CN¥9.4B ) overtreffen de langetermijnschulden ( CN¥350.9M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 600587 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 600587 is de afgelopen 5 jaar gedaald van 82.5% naar 13.5%.

Schuldendekking: De schuld van 600587 wordt goed gedekt door de operationele kasstroom ( 66.4% ).

Rentedekking: 600587 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Shinva Medical InstrumentLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 3Q 2023)

Now 23% undervalued

Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven